IL6 and colorectal carcinoma: In another line of investigation, Peuker et al. highlighted that IL-6 could enhance B7-H3 expression in CRC through STAT3 signaling, implicating myeloid calcineurin—activated by microbiota—in mediating IL-6 production, which promotes CD276 expression and suppresses anti-tumor responses [72].